Clinical Trial Update: A Phase 1 Trial of TST of PD 0332991 Followed by Cytarabine and Mitoxantrone for Adults With Relapsed and Refractory Acute Leukemias and High-Risk Myelodysplasia [Phase 1]

View source ↗

Summary

A Phase 1 trial of PD-0332991 (palbociclib) followed by cytarabine and mitoxantrone in adults with relapsed or refractory acute leukemia and high-risk myelodysp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• High-risk Myelodysplastic Syndrome
• Leukemia

Drugs mentioned

• CYTARABINE (CYTARABINE)
• Mitoxantrone (mitoxantrone)
• Palbociclib (PD-0332991) (palbociclib)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Relapsed Acute Leukemia, Refractory Acute Leukemia | Phase 1 | Status: TERMINATED | Results posted: 2013-09-09